| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
20,814 |
16,068 |
$2.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,672 |
9,491 |
$96K |
| 96127 |
|
1,438 |
1,304 |
$19K |
| 3008F |
|
989 |
819 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
414 |
366 |
$10K |
| 90686 |
|
485 |
462 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
541 |
473 |
$8K |
| 99406 |
|
1,207 |
1,054 |
$6K |
| 90834 |
Psychotherapy, 45 minutes with patient |
336 |
184 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
98 |
94 |
$5K |
| 81002 |
|
292 |
254 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,966 |
2,472 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
244 |
225 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
596 |
512 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
55 |
46 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
260 |
243 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,589 |
841 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
36 |
$2K |
| T1016 |
Case management, each 15 minutes |
35 |
17 |
$51.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
28 |
28 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$0.00 |
| 3078F |
|
12 |
12 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
14 |
$0.00 |
| 1036F |
|
27 |
25 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
32 |
20 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
16 |
14 |
$0.00 |
| 3079F |
|
13 |
12 |
$0.00 |
| 3074F |
|
22 |
21 |
$0.00 |